| |
1997
- Callahan LF, Pincus T, Huston JW, 3rd, Brooks RH, Nance EP, Jr., Kaye JJ. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years. Arthritis Care Res. 1997;10(6):381-94.
- Cibere J, Sibley J, Haga M. Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum. 1997;40(9):1580-6.
- Clarke AE, Zowall H, Levinton C, et al. Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol. 1997;24(6):1051-60.
- Fries J. Can preventive gerontology be on the way? [editorial]. Amer Jnl of Public Health. 1997;87:1591-3.
- Fries J, Williams C, Singh G, Ramey D. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. Jnl of Rheumatology. 1997;24:838-44.
- Fries JF. Reducing the need and demand for medical care: implications for quality management and outcome improvement. Qual Manag Health Care. 1997;6(1):34-44.
- Fries JF, Carey C, McShane DJ. Patient education in arthritis: randomized controlled trial of a mail- delivered program. J Rheumatol. 1997;24(7):1378-83.
- Fries JF, Ramey DR. "Arthritis specific" global health analog scales assess "generic" health related quality-of-life in patients with rheumatoid arthritis. J Rheumatol. 1997;24(9):1697-702.
- Holman HR, Lorig KR. Patient education: essential to good health care for patients with chronic arthritis. Arthritis Rheum. 1997;40(8):1371-3.
- Lane NE. Pain management in osteoarthritis: the role of COX-2 inhibitors. J Rheumatol. 1997;24 Suppl 49:20-4.
- Leigh J, Dhir R. Schooling and frailty among seniors. Economics of Education Review. 1997;16:45-57.
- Pincus T, Larsen A, Brooks RH, Kaye J, Nance EP, Callahan LF. Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score. J Rheumatol. 1997;24(11):2106-12.
- Pincus T, Stein CM. Why randomized controlled clinical trials do not depict accurately long- term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies. Clin Exp Rheumatol. 1997;15 Suppl 17:S27-38.
- Pincus T, Stein CM, Wolfe F. "No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: a contemporary goal for rheumatology care? Clin Exp Rheumatol. 1997;15(6):591-6.
- Ward MM. Psychological health and duration of treatment with second line antirheumatic medication: means to an end? J Rheumatol. 1997;24(11):2064-5.
- Ward MM. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis. J Rheumatol. 1997;24(1):35-42.
- Wolfe F. The prognosis of rheumatoid arthritis: assessment of disease activity and disease severity in the clinic. Am J Med. 1997;103(6A):12S-18S.
- Wolfe F. Adverse drug reactions of DMARDs and DC-ARTs in rheumatoid arthritis. Clin Exp Rheumatol. 1997;15 Suppl 17:S75-81.
- Wolfe F. Practical issues in psychosocial measures. J Rheumatol. 1997;24(5):990-3.
- Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol. 1997;24(8):1477-85.
- Wolfe F, Anderson J, Harkness D, et al. Work and disability status of persons with fibromyalgia. J Rheumatol. 1997;24(6):1171-8.
- Wolfe F, Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol. 1997;36(7):786-93.
|